Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability.

Narbutt, Joanna; Niedzwiedz, Michal; Lesiak, Aleksandra; Ceryn, Justyna; Skibinska, Malgorzata

Narbutt, Joanna; Niedzwiedz, Michal; Lesiak, Aleksandra; Ceryn, Justyna; Skibinska, Malgorzata.

Afiliación

Narbutt J; Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland.
Niedzwiedz M; Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland.
Lesiak A; Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland.
Ceryn J; Department of Dermatology, Pediatric Dermatology and Dermatological Oncology, Medical University of Lodz, Lodz, Poland.
Skibinska M; International Doctoral School of the Medical University of Lodz, Lodz, Poland.

Patient Prefer Adherence ; 17: 421-431, 2023.

Article en En | MEDLINE | ID: mdl-36815128

Palabras clave

acceptability; pediatric psoriasis; psoriasis vulgaris; secukinumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Screening_studies Aspecto: Patient_preference Idioma: En Revista: Patient Prefer Adherence Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google